Skip to main content
. 2022 Jan 10;12:781623. doi: 10.3389/fphar.2021.781623

FIGURE 8.

FIGURE 8

Inhibition of the activity of TAK1, c-Jun, and IκB-α in RCC xenografts in response to treatment by NVP-BEZ235, PP242, and Rapamycin. Sections of all xenograft tumor tissues formed by (A) 786-0 and (B) A498 renal cancer cells were examined by immunohistochemical staining using anti-p-TAK1, anti-p-c-Jun, and anti-p-IκB-α antibodies. Representative images were taken at a magnification 200× (inset 400×). A group of untreated mice served as control.